Raymond James & Associates’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-463
| Closed | -$23K | – | 3993 |
|
|
2021
Q3 | $23K | Buy |
463
+3
| +0.7% | +$149 | ﹤0.01% | 3890 |
|
|
2021
Q2 | $40K | Buy |
+460
| New | +$40K | ﹤0.01% | 3849 |
|
|
2020
Q2 | – | Sell |
-480
| Closed | -$7K | – | 3416 |
|
|
2020
Q1 | $7K | Hold |
480
| – | – | ﹤0.01% | 3379 |
|
|
2019
Q4 | $12K | Hold |
480
| – | – | ﹤0.01% | 3534 |
|
|
2019
Q3 | $9K | Hold |
480
| – | – | ﹤0.01% | 3477 |
|
|
2019
Q2 | $12K | Hold |
480
| – | – | ﹤0.01% | 3487 |
|
|
2019
Q1 | $17K | Hold |
480
| – | – | ﹤0.01% | 3461 |
|
|
2018
Q4 | $12K | Hold |
480
| – | – | ﹤0.01% | 3408 |
|
|
2018
Q3 | $21K | Hold |
480
| – | – | ﹤0.01% | 3471 |
|
|
2018
Q2 | $28K | Hold |
480
| – | – | ﹤0.01% | 3424 |
|
|
2018
Q1 | $37K | Hold |
480
| – | – | ﹤0.01% | 3298 |
|
|
2017
Q4 | $46K | Buy |
+480
| New | +$46K | ﹤0.01% | 3226 |
|